| 000 | 01428 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250516122249.0 | ||
| 264 | 0 | _c20130610 | |
| 008 | 201306s 0 0 eng d | ||
| 022 | _a1365-2710 | ||
| 024 | 7 |
_a10.1111/jcpt.12015 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMu, L-L | |
| 245 | 0 | 0 |
_aInvestigation of chiral inversion and pharmacokinetics of laevo-ornidazole by high-performance liquid chromatography. _h[electronic resource] |
| 260 |
_bJournal of clinical pharmacy and therapeutics _cFeb 2013 |
||
| 300 |
_a31-5 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Randomized Controlled Trial; Validation Study | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntiprotozoal Agents _xadministration & dosage |
| 650 | 0 | 4 | _aChina |
| 650 | 0 | 4 |
_aChromatography, High Pressure Liquid _xmethods |
| 650 | 0 | 4 | _aCross-Over Studies |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFood-Drug Interactions |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aOrnidazole _xadministration & dosage |
| 650 | 0 | 4 | _aStereoisomerism |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aCheng, Z-N | |
| 700 | 1 | _aGuo, X | |
| 700 | 1 | _aLuo, X | |
| 700 | 1 | _aYu, P | |
| 773 | 0 |
_tJournal of clinical pharmacy and therapeutics _gvol. 38 _gno. 1 _gp. 31-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/jcpt.12015 _zAvailable from publisher's website |
| 999 |
_c22279037 _d22279037 |
||